Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Head and Neck Cancer

Free Subscription Articles published in Surgery Retrieve available abstracts of 131 articles: HTML format

Single Articles

May 2024
1. LUNARDI N, Jacob A, Elfenbein D, Schneider DF, et al
   Don't chase the adenoma: A probabilistic approach to imaging before parathyroidectomy.
   Surgery. 2024;175:1299-1304.
   PubMed     Abstract available
   
   
   
2. MA S, Zhu J, Xue M, Shen Y, et al
   Early postoperative endoscopy for predicting anastomotic leakage after minimally invasive esophagectomy: A large-volume retrospective study.
   Surgery. 2024;175:1305-1311.
   PubMed     Abstract available
   
   
   April 2024
3. CHALLINE A, Kirouani M, Markar SR, Tzedakis S, et al
   MIRO study: Do the results of a randomized controlled trial apply in a real population?
   Surgery. 2024;175:1055-1062.
   PubMed     Abstract available
   
   
   March 2024
4. PIERCE K, Philips P, Egger ME, Scoggins CR, et al
   Developing sarcopenia during neoadjuvant therapy is associated with worse survival in esophageal adenocarcinoma patients.
   Surgery. 2024;175:718-725.
   PubMed     Abstract available
   
   
   February 2024
5. DYAS AR, Mungo B, Bronsert MR, Stuart CM, et al
   National trends in technique use for esophagectomy: Does primary surgeon specialty matter?
   Surgery. 2024;175:353-359.
   PubMed     Abstract available
   
   
   
6. DU J, Zeng T, Zhang S, Chen M, et al
   Comparison of indocyanine green-near-infrared fluorescence guided and traditional mediastinal lymphadenectomy during radical esophagectomy: A randomized controlled trial.
   Surgery. 2024;175:347-352.
   PubMed     Abstract available
   
   
   
7. FUJITA T, Sato K, Fujiwara N, Kajiyama D, et al
   A novel imaging technology to assess tissue oxygen saturation and its correlation with indocyanine green in the gastric conduit during thoracic esophagectomy.
   Surgery. 2024;175:360-367.
   PubMed     Abstract available
   
   
   January 2024
8. HEO DB, Won HR, Tae K, Kang YE, et al
   Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
   Surgery. 2024 Jan 27:S0039-6060(23)00967-4. doi: 10.1016/j.surg.2023.
   PubMed     Abstract available
   
   
   
9. LUND S, Schmitz JJ, Foster T, Dy B, et al
   Ethanol ablation of papillary thyroid carcinoma nodal metastases: Long-term outcomes.
   Surgery. 2024 Jan 8:S0039-6060(23)00908-X. doi: 10.1016/j.surg.2023.
   PubMed     Abstract available
   
   
   
10. LEE-SAXTON YJ, Palacardo F, Greenberg JA, Egan CE, et al
    Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.
    Surgery. 2024;175:215-220.
    PubMed     Abstract available
    
    
    
11. WRIGHT K, Fisher JC, Rothberger GD, Prescott JD, et al
    Incidental (68)Ga-DOTATATE uptake in thyroid nodules: Is guideline-directed management still appropriate?
    Surgery. 2024;175:228-233.
    PubMed     Abstract available
    
    
    December 2023
12. YAMAMOTO M, Miyauchi A, Ito Y, Fujishima M, et al
    Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
    Surgery. 2023 Dec 22:S0039-6060(23)00887-5. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
13. HU QL, Chen L, Kuo EJ, Lee JA, et al
    A national study of postoperative thyroid hormone supplementation rates after thyroid lobectomy.
    Surgery. 2023 Dec 13:S0039-6060(23)00871-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
14. OWUSU-BRACKETT N, Chakedis JM, Dedhia P, Gilliam C, et al
    Efficacy and safety of near-infrared fluorescence identification of the thoracic duct during left lateral neck dissection.
    Surgery. 2023 Dec 5:S0039-6060(23)00683-9. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    November 2023
15. SZABO YAMASHITA T, Shirali AS, Meas S, Sarli V, et al
    Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?
    Surgery. 2023 Nov 21:S0039-6060(23)00636-0. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
16. STURGEON C
    Addressing financial toxicity in thyroid cancer survivors in the United States.
    Surgery. 2023 Nov 10:S0039-6060(23)00755-9. doi: 10.1016/j.surg.2023.
    PubMed    
    
    
    
17. RUSSELL JO, Desai DD, Noel JE, Hussein M, et al
    Radiofrequency ablation of benign thyroid nodules: A prospective, multi-institutional North American experience.
    Surgery. 2023 Nov 10:S0039-6060(23)00725-0. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
18. SWANSON J, Roat-Shumway S, Cohn T, Luchette FA, et al
    Esophageal cancer: Does inaccuracy in clinical staging affect our ability to reach optimal outcomes?
    Surgery. 2023 Nov 4:S0039-6060(23)00518-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
19. RAGHUNATHAN R, Longstaff XR, Hughes EG, Li SJ, et al
    Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with Hurthle cell cytology.
    Surgery. 2023 Nov 3:S0039-6060(23)00634-7. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
20. LIN AC, Liu Z, Lee J, Ranvier GF, et al
    Generating a multimodal artificial intelligence model to differentiate benign and malignant follicular neoplasms of the thyroid: A proof-of-concept study.
    Surgery. 2023 Nov 2:S0039-6060(23)00635-9. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    October 2023
21. GIMBLET GR, Whitt J, Houson HA, Lin D, et al
    Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.
    Surgery. 2023 Oct 31:S0039-6060(23)00631-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
22. TUMATI A, Egan CE, Lee-Saxton YJ, Marshall TE, et al
    Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.
    Surgery. 2023 Oct 29:S0039-6060(23)00626-8. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
23. CARLISLE KM, Brown JP, Kim J, Turner DJ, et al
    Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis.
    Surgery. 2023 Oct 21:S0039-6060(23)00638-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
24. COLLINS RA, McManus C, Kuo EJ, Liou R, et al
    The impact of social determinants of health on thyroid cancer mortality and time to treatment.
    Surgery. 2023 Oct 21:S0039-6060(23)00627-X. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
25. HUSSEIN M, Toraih E, Issa PP, Omar M, et al
    From ablation to operation: Unraveling the surgical outcomes and complications of thyroidectomy after radiofrequency ablation.
    Surgery. 2023 Oct 20:S0039-6060(23)00629-3. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
26. ZHAO HH, Wilhelm SM
    Pediatric thyroid cancer: Socioeconomic disparities and their impact on access to care.
    Surgery. 2023 Oct 18:S0039-6060(23)00600-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
27. DRALLE H, Brandenburg T, Weber F, Fuhrer-Sakel D, et al
    Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy.
    Surgery. 2023 Oct 9:S0039-6060(23)00589-5. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    September 2023
28. VERM RA, Baker MM, Cohn T, Park S, et al
    Fragmented care, Commission on Cancer accreditation, and overall survival in patients receiving surgery and chemotherapy for esophageal cancer.
    Surgery. 2023 Sep 22:S0039-6060(23)00504-4. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
29. AKGUN E, Romero-Velez G, Berber E
    Assessing the efficacy of thyroid nodule radiofrequency ablation using patient-reported outcome measures.
    Surgery. 2023 Sep 21:S0039-6060(23)00514-7. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
30. SCHURING N, Donlon NE, Hagens ERC, Gootjes D, et al
    External validation of a nomogram predicting conditional survival after tri-modality treatment of esophageal cancer.
    Surgery. 2023 Sep 19:S0039-6060(23)00502-0. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
31. TERANISHI R, Makino T, Tanaka K, Yamashita K, et al
    Corrigendum to "Long-term survival and prognostic factors associated with curative conversion surgery for cT4b esophageal squamous cell carcinoma: Analysis of 200 consecutive cases": Surgery. 2023 Sep;174(3):558-566. doi:10.1016/j.surg.2023.05.040.
    Surgery. 2023 Sep 5:S0039-6060(23)00528-7. doi: 10.1016/j.surg.2023.
    PubMed    
    
    
    August 2023
32. MONTGOMERY KB, Fazendin JM, Broman KK
    Evolving variation in the extent of surgery for low-risk papillary thyroid cancer in the United States.
    Surgery. 2023 Aug 5:S0039-6060(23)00428-2. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
33. LAYDI M, Doussot A, Lakkis Z, Mathieu P, et al
    Anatomic patterns of anastomotic leaks after Ivor Lewis esophagectomy for cancer: Impact on management and outcomes.
    Surgery. 2023;174:247-251.
    PubMed     Abstract available
    
    
    July 2023
34. ZHANG J, Wang Y, Zhang T, Xu D, et al
    A clinical nomogram for predicting small bowel obstruction after extubation after radical resection of esophageal cancer and jejunostomy.
    Surgery. 2023 Jul 24:S0039-6060(23)00404-X. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    June 2023
35. STEVENS A, Meier J, Bhat A, Knight SJ, et al
    Reassessing surgical guidelines for papillary thyroid cancer impact on survival: Expanding indications for lobectomy.
    Surgery. 2023 Jun 29:S0039-6060(23)00328-8. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
36. TERANISHI R, Makino T, Tanaka K, Yamashita K, et al
    Long-term survival and prognostic factors associated with curative conversion surgery for ct4b esophageal squamous cell carcinoma: Analysis of 200 consecutive cases.
    Surgery. 2023 Jun 28:S0039-6060(23)00335-5. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    May 2023
37. KUO TC, Chen KY, Lai CW, Wang YC, et al
    Synergic evacuation device helps smoke control during endoscopic thyroid surgery.
    Surgery. 2023 May 16:S0039-6060(23)00187-3. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    March 2023
38. KANG YJ, Stybayeva G, Hwang SH
    Surgical completeness and safety of minimally invasive thyroidectomy in patients with thyroid cancer: A network meta-analysis.
    Surgery. 2023 Mar 25:S0039-6060(23)00110-1. doi: 10.1016/j.surg.2023.
    PubMed     Abstract available
    
    
    
39. SWANSON J, Littau M, Tonelli C, Cohn T, et al
    The role of endoscopic resection in early-stage esophageal adenocarcinoma: Esophagectomy is associated with improved survival in patients presenting with clinical stage T1bN0 disease.
    Surgery. 2023;173:693-701.
    PubMed     Abstract available
    
    
    February 2023
40. OGUMA J, Ishiyama K, Kurita D, Kanematsu K, et al
    Oncologic significance of lymphovascular invasion in patients with superficial esophageal squamous cell carcinoma reaching the muscularis mucosae or with slight invasion of the submucosa.
    Surgery. 2023 Feb 15:S0039-6060(22)01086-8. doi: 10.1016/j.surg.2022.
    PubMed     Abstract available
    
    
    
41. QURESHI MM, Kam A, Suzuki K, Litle V, et al
    Association between hospital safety-net burden and receipt of trimodality therapy and survival for patients with esophageal cancer.
    Surgery. 2023 Feb 9:S0039-6060(22)01080-7. doi: 10.1016/j.surg.2022.
    PubMed     Abstract available
    
    
    January 2023
42. DAS S, Jha CK, Singh PK
    Extent of surgery in localized, sporadic medullary thyroid carcinoma: Can we avoid central compartment lymph node dissection?
    Surgery. 2023 Jan 11:S0039-6060(22)01043-1. doi: 10.1016/j.surg.2022.
    PubMed    
    
    
    
43. WRIGHT K, Brandler TC, Fisher JC, Rothberger GD, et al
    The clinical significance of the American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) category 5 thyroid nodules: Not as risky as we think?
    Surgery. 2023;173:239-245.
    PubMed     Abstract available
    
    
    
44. BAREGAMIAN N, Sekhar KR, Krystofiak ES, Vinogradova M, et al
    Engineering functional 3-dimensional patient-derived endocrine organoids for broad multiplatform applications.
    Surgery. 2023;173:67-75.
    PubMed     Abstract available
    
    
    December 2022
45. THAKUR PS, Kumar C
    Critical appraisal of total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves' disease.
    Surgery. 2022 Dec 15:S0039-6060(22)00994-1. doi: 10.1016/j.surg.2022.
    PubMed    
    
    
    
46. WALLER GC, Patel DJ, Baker MS
    Early-stage gastric and gastroesophageal junction cancer: Is there a survival benefit to neoadjuvant therapy?
    Surgery. 2022;172:1753-1758.
    PubMed     Abstract available
    
    
    November 2022
47. CARTY SE
    Real-time thyroid nodule care.
    Surgery. 2022 Nov 7. pii: S0039-6060(22)00849-2. doi: 10.1016/j.surg.2022.
    PubMed    
    
    
    
48. UNDERWOOD HJ, Mott NM, Saucke MC, Roman BR, et al
    What do patients want to know about surgery for low-risk thyroid cancer? A qualitative study.
    Surgery. 2022 Nov 3. pii: S0039-6060(22)00725-5. doi: 10.1016/j.surg.2022.
    PubMed     Abstract available
    
    
    
49. KUO EJ, Oh A, Hu Y, McManus CM, et al
    If the price is right: Cost-effectiveness of radiofrequency ablation versus thyroidectomy in the treatment of benign thyroid nodules.
    Surgery. 2022 Nov 2. pii: S0039-6060(22)00800-5. doi: 10.1016/j.surg.2022.
    PubMed     Abstract available
    
    
    
50. HUMPHREYS BM, Memeh KO, Funkhouser A, Vaghaiwalla TM, et al
    Prognostic factors and survival analysis of Hurthle cell carcinoma: A population-based study.
    Surgery. 2022;172:1379-1384.
    PubMed     Abstract available
    
    
    October 2022
51. FINN CB, Wirtalla C, Mascuilli T, Krumeich LN, et al
    Simulated data-driven hospital selection for surgical treatment of well-differentiated thyroid cancer in older adults.
    Surgery. 2022 Oct 21. pii: S0039-6060(22)00724.
    PubMed     Abstract available
    
    
    
52. LIU JB, Ramonell KM, Carty SE, McCoy KL, et al
    Association of comprehensive thyroid cancer molecular profiling with tumor phenotype and cancer-specific outcomes.
    Surgery. 2022 Oct 19. pii: S0039-6060(22)00723.
    PubMed     Abstract available
    
    
    
53. WOODS RSR, Fitzgerald CWR, Valero C, Lopez J, et al
    Surgical management of T1/T2 node-negative papillary thyroid cancer with tall cell histology: Is lobectomy enough?
    Surgery. 2022 Oct 15. pii: S0039-6060(22)00720.
    PubMed     Abstract available
    
    
    
54. RAMONELL KM, Ohori NP, Liu JB, McCoy KL, et al
    Changes in thyroid nodule cytology rates after institutional implementation of the Thyroid Imaging Reporting and Data System.
    Surgery. 2022 Oct 14. pii: S0039-6060(22)00802.
    PubMed     Abstract available
    
    
    
55. DELMAN AM, Turner KM, Ammann AM, Sisak S, et al
    The national rate of malignancy among Bethesda III, IV, and V thyroid nodules is higher than expected: A NSQIP analysis.
    Surgery. 2022 Oct 11. pii: S0039-6060(22)00685.
    PubMed     Abstract available
    
    
    
56. MA EZ, Kuo JH, Malek R, Turner DJ, et al
    Total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves' disease.
    Surgery. 2022 Oct 5. pii: S0039-6060(22)00674-2. doi: 10.1016/j.surg.2022.
    PubMed     Abstract available
    
    
    
57. BARRANCO H, Fazendin J, Lindeman B, Chen H, et al
    Thyroid hormone replacement following lobectomy: Long-term institutional analysis 15 years after surgery.
    Surgery. 2022 Oct 3. pii: S0039-6060(22)00677-8. doi: 10.1016/j.surg.2022.
    PubMed     Abstract available
    
    
    September 2022
58. CHIU AS, Saucke MC, Bushaw K, Voils CI, et al
    The relative importance of treatment outcomes to surgeons' recommendations for low-risk thyroid cancer.
    Surgery. 2022 Sep 28. pii: S0039-6060(22)00320.
    PubMed     Abstract available
    
    
    
59. FRISCO NA, Gunn AH, Thomas SM, Stang MT, et al
    Medullary thyroid cancer with RET V804M mutation: more indolent than expected?
    Surgery. 2022 Sep 20. pii: S0039-6060(22)00323.
    PubMed     Abstract available
    
    
    August 2022
60. CONROY PC, Wilhelm A, Calthorpe L, Ullmann TM, et al
    Endocrine surgeons are performing more thyroid lobectomies for low-risk differentiated thyroid cancer since the 2015 ATA guidelines.
    Surgery. 2022 Aug 21. pii: S0039-6060(22)00498.
    PubMed     Abstract available
    
    
    
61. LIANG W, Shi J, Zhang H, Lv G, et al
    Total thyroidectomy vs thyroid lobectomy for localized medullary thyroid cancer in adults: A propensity-matched survival analysis.
    Surgery. 2022 Aug 19. pii: S0039-6060(22)00489.
    PubMed     Abstract available
    
    
    
62. BEER A, Reber A, Paireder M, Schoppmann SF, et al
    Tumor cell budding in preoperative biopsies of esophageal and gastroesophageal junction carcinoma independently predicts survival in a grade-dependent manner.
    Surgery. 2022;172:567-574.
    PubMed     Abstract available
    
    
    July 2022
63. ABE T, Oshikiri T, Goto H, Kato T, et al
    Thoracic cavity-to-cage ratio is a predictor of technical difficulties in minimally invasive esophagectomy.
    Surgery. 2022;172:145-149.
    PubMed     Abstract available
    
    
    
64. GOOSZEN JAH, Eshuis WJ, Blom RLGM, van Dieren S, et al
    The effect of preoperative body mass index on short-term outcome after esophagectomy for cancer: A nationwide propensity score-matched analysis.
    Surgery. 2022;172:137-144.
    PubMed     Abstract available
    
    
    June 2022
65. FUJITA H, Motoyama S, An J, Nagakai Y, et al
    Peritumoral CD16b positive-neutrophil accumulation strongly correlates with regional lymph node metastasis in thoracic esophageal squamous cell cancer.
    Surgery. 2022;171:1535-1542.
    PubMed     Abstract available
    
    
    May 2022
66. PAI E, Kumar T
    Intrathoracic versus cervical anastomosis in esophagectomy for esophageal cancer: Are these procedures indeed comparable?
    Surgery. 2022 May 31. pii: S0039-6060(22)00310.
    PubMed    
    
    
    
67. HAMAI Y, Emi M, Ibuki Y, Murakami Y, et al
    Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy.
    Surgery. 2022 May 3. pii: S0039-6060(22)00218-5. doi: 10.1016/j.surg.2022.
    PubMed     Abstract available
    
    
    
68. PRASAD P, Wallace L, Navidi M, Phillips AW, et al
    Learning curves in minimally invasive esophagectomy: A systematic review and evaluation of benchmarking parameters.
    Surgery. 2022;171:1247-1256.
    PubMed     Abstract available
    
    
    April 2022
69. YOU J, Zhang H, Li W, Dai N, et al
    Intrathoracic versus cervical anastomosis in esophagectomy for esophageal cancer: A meta-analysis of randomized controlled trials.
    Surgery. 2022 Apr 7. pii: S0039-6060(22)00149-0. doi: 10.1016/j.surg.2022.
    PubMed     Abstract available
    
    
    March 2022
70. DING AS, Xie DX, Zhang L, Creighton FX, et al
    Public perceptions of radiofrequency ablation versus standard surgery for benign thyroid nodules.
    Surgery. 2022 Mar 2. pii: S0039-6060(22)00062-9. doi: 10.1016/j.surg.2022.
    PubMed     Abstract available
    
    
    February 2022
71. GRAVES CE, Hope TA, Suh I
    Response to "Preoperative localization in primary hyperparathyroidism: Views from the developing world".
    Surgery. 2022;171:564.
    PubMed    
    
    
    
72. TYAGI N, Gaurav K, Anand A, Sonkar AA, et al
    Preoperative localization in primary hyperparathyroidism: Views from developing world.
    Surgery. 2022;171:563-564.
    PubMed    
    
    
    
73. KOSHY RM, Brown JM, Chmelo J, Watkinson T, et al
    Anastomotic stricture after Ivor Lewis esophagectomy: An evaluation of incidence, risk factors, and treatment.
    Surgery. 2022;171:393-398.
    PubMed     Abstract available
    
    
    January 2022
74. BABAZADEH NT, Sinclair TJ, Krishnamurthy V, Jin J, et al
    Thyroid nodule molecular profiling: The clinical utility of Afirma Xpression Atlas for nodules with Afirma Genomic Sequencing Classifier-suspicious results.
    Surgery. 2022;171:155-159.
    PubMed     Abstract available
    
    
    
75. YAP A, Hope TA, Graves CE, Kluijfhout W, et al
    A cost-utility analysis of 18F-fluorocholine-positron emission tomography imaging for localizing primary hyperparathyroidism in the United States.
    Surgery. 2022;171:55-62.
    PubMed     Abstract available
    
    
    
76. GRAVES CE, Hope TA, Kim J, Pampaloni MH, et al
    Superior sensitivity of (18)F-fluorocholine: PET localization in primary hyperparathyroidism.
    Surgery. 2022;171:47-54.
    PubMed     Abstract available
    
    
    
77. SHARIQ OA, Lines KE, English KA, Jafar-Mohammadi B, et al
    Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomes.
    Surgery. 2022;171:77-87.
    PubMed     Abstract available
    
    
    December 2021
78. ANGERAMO CA, Bras Harriott C, Casas MA, Schlottmann F, et al
    Minimally invasive Ivor Lewis esophagectomy: Robot-assisted versus laparoscopic-thoracoscopic technique. Systematic review and meta-analysis.
    Surgery. 2021;170:1692-1701.
    PubMed     Abstract available
    
    
    November 2021
79. YOU JY, Park DW, Anuwong A, Kim HY, et al
    Reply to "Prevention of transoral thyroidectomy complications: An analysis of surgical outcomes in 423 consecutive series."
    Surgery. 2021 Nov 19. pii: S0039-6060(21)01047.
    PubMed    
    
    
    
80. KUO JH, Sinclair CF, Lang B, Spiezia S, et al
    A comprehensive review of interventional ablation techniques for the management of thyroid nodules and metastatic lymph nodes.
    Surgery. 2021 Nov 11. pii: S0039-6060(21)00853.
    PubMed     Abstract available
    
    
    
81. TVERSKOV V, Wiesel O, Solomon D, Orgad R, et al
    The impact of cervical anastomotic leak after esophagectomy on long-term survival of patients with esophageal cancer.
    Surgery. 2021 Nov 6. pii: S0039-6060(21)00969-7. doi: 10.1016/j.surg.2021.
    PubMed     Abstract available
    
    
    
82. LYNCH CA, Bethi M, Tang A, Lee P, et al
    Thyroid nodules >4 cm with atypia of undetermined significance cytology independently associate with malignant pathology.
    Surgery. 2021 Nov 3. pii: S0039-6060(21)00787-X. doi: 10.1016/j.surg.2021.
    PubMed     Abstract available
    
    
    
83. LINHARES SM, Handelsman R, Picado O, Farra JC, et al
    Fine needle aspiration and the Bethesda system: Correlation with histopathology in 1,228 surgical patients.
    Surgery. 2021;170:1364-1368.
    PubMed     Abstract available
    
    
    
84. WATTS F, Palme CE, Porceddu S, Sundaresan P, et al
    Clinician perspectives on the factors influencing prognostic stratification by the American Joint Commission on Cancer Head and Neck Cutaneous Squamous Cell Carcinoma Staging.
    Surgery. 2021;170:1467-1473.
    PubMed     Abstract available
    
    
    October 2021
85. ZHANG Y, Wang K, Liu J, Xu S, et al
    Surgical management of parapharyngeal lymph node metastases from thyroid carcinoma with transcervical approach.
    Surgery. 2021 Oct 25. pii: S0039-6060(21)00876.
    PubMed     Abstract available
    
    
    
86. MACKINNEY EC, Kuchta KM, Winchester DJ, Khokar AM, et al
    Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer.
    Surgery. 2021 Oct 16. pii: S0039-6060(21)00796.
    PubMed     Abstract available
    
    
    September 2021
87. THIESMEYER JW, Limberg J, Ullmann TM, Greenberg JA, et al
    Insurance type is associated with appropriate use of surgical and adjuvant care for differentiated thyroid carcinoma.
    Surgery. 2021 Sep 30. pii: S0039-6060(21)00794.
    PubMed     Abstract available
    
    
    
88. MACHENS A, Kaatzsch P, Lorenz K, Horn LC, et al
    Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer.
    Surgery. 2021 Sep 30. pii: S0039-6060(21)00765.
    PubMed     Abstract available
    
    
    
89. HARRIES V, McGill M, Yuan A, Wang LY, et al
    Does macroscopic extrathyroidal extension to the strap muscles alone affect survival in papillary thyroid carcinoma?
    Surgery. 2021 Sep 29. pii: S0039-6060(21)00863.
    PubMed     Abstract available
    
    
    
90. KELZ RR
    Thyroid surgery: surgical health equity, best practices in surgical education, and leveraging the power of collaboration.
    Surgery. 2021 Sep 25. pii: S0039-6060(21)00855.
    PubMed    
    
    
    
91. HOLM TM, Bian ZC, Manupati K, Guan JL, et al
    Inhibition of autophagy mitigates cell migration and invasion in thyroid cancer.
    Surgery. 2021 Sep 23. pii: S0039-6060(21)00795.
    PubMed     Abstract available
    
    
    
92. BONA D, Lombardo F, Matsushima K, Cavalli M, et al
    Three-field versus two-field lymphadenectomy for esophageal squamous cell carcinoma: A long-term survival meta-analysis.
    Surgery. 2021 Sep 17. pii: S0039-6060(21)00844.
    PubMed     Abstract available
    
    
    
93. GREENBERG JA, Thiesmeyer JW, Ullmann TM, Egan CE, et al
    Association of the Affordable Care Act with access to highest-volume centers for patients with thyroid cancer.
    Surgery. 2021 Sep 3. pii: S0039-6060(21)00685-1. doi: 10.1016/j.surg.2021.
    PubMed     Abstract available
    
    
    
94. GENPENG L, Pan Z, Tao W, Rixiang G, et al
    Prognostic implications of extranodal extension in papillary thyroid carcinomas: A propensity score matching analysis and proposal for incorporation into current tumor, lymph node, metastasis staging.
    Surgery. 2021 Sep 2. pii: S0039-6060(21)00701-7. doi: 10.1016/j.surg.2021.
    PubMed     Abstract available
    
    
    August 2021
95. AHN JH, Kwak JH, Yoon SG, Yi JW, et al
    A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma.
    Surgery. 2021 Aug 12. pii: S0039-6060(21)00611.
    PubMed     Abstract available
    
    
    
96. HOLOUBEK SA, MacKinney EC, Khokar AM, Kuchta KM, et al
    Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.
    Surgery. 2021 Aug 10. pii: S0039-6060(21)00571.
    PubMed     Abstract available
    
    
    
97. YOUSSEF MR, Attia AS, Omar M, Aboueisha M, et al
    Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
    Surgery. 2021 Aug 10. pii: S0039-6060(21)00576.
    PubMed     Abstract available
    
    
    
98. BECK AC, Rajan A, Landers S, Kelley S, et al
    Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.
    Surgery. 2021 Aug 3. pii: S0039-6060(21)00653-X. doi: 10.1016/j.surg.2021.
    PubMed     Abstract available
    
    
    
99. KWAK MS, Eun YG, Lee YC
    Benefit of postoperative radiotherapy in patients with oropharyngeal squamous cell carcinoma in human papillomavirus (HPV) era: A Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Surgery. 2021;170:541-549.
    PubMed     Abstract available
    
    
    July 2021
100. LI C, Lopez B, Fligor S, Broekhuis JM, et al
     Long-term voice changes after thyroidectomy: Results from a validated survey.
     Surgery. 2021 Jul 31. pii: S0039-6060(21)00686.
     PubMed     Abstract available
     
     
     
101. ZHAO B, Aggarwal A, Marshall JA, Barletta JA, et al
     Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves survival in a murine model of anaplastic thyroid cancer.
     Surgery. 2021 Jul 29. pii: S0039-6060(21)00572.
     PubMed     Abstract available
     
     
     
102. KIM J, Sun Z, Cummins M, Donohue KC, et al
     Implications of radiofrequency ablation in patients undergoing thyroid surgery for benign disease in the United States.
     Surgery. 2021 Jul 22. pii: S0039-6060(21)00616.
     PubMed     Abstract available
     
     
     
103. DELMAN AM, Turner KM, Ammann AM, Tang A, et al
     Avoiding delays in time to renal transplantation: Pretransplant thyroid malignancy does not affect patient or graft survival after renal transplantation.
     Surgery. 2021 Jul 21. pii: S0039-6060(21)00455.
     PubMed     Abstract available
     
     
     
104. SZABO YAMASHITA T, Rogers RT, Foster TR, Lyden ML, et al
     Medullary thyroid cancer: What is the optimal management of the lateral neck in a node negative patient at index operation?
     Surgery. 2021 Jul 18. pii: S0039-6060(21)00570.
     PubMed     Abstract available
     
     
     
105. LIU Z, Li Y, Wang Y, Xiang C, et al
     Comparison of the transoral endoscopic thyroidectomy vestibular approach and open thyroidectomy: A propensity score-matched analysis of surgical outcomes and safety in the treatment of papillary thyroid carcinoma.
     Surgery. 2021 Jul 17. pii: S0039-6060(21)00643.
     PubMed     Abstract available
     
     
     
106. HU QL, Schumm MA, Zanocco KA, Yeh MW, et al
     Cost analysis of reflexive versus selective molecular testing for indeterminate thyroid nodules.
     Surgery. 2021 Jul 17. pii: S0039-6060(21)00555.
     PubMed     Abstract available
     
     
     
107. FENG JW, Qu Z, Ye J, Hong LZ, et al
     Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.
     Surgery. 2021 Jul 15. pii: S0039-6060(21)00635.
     PubMed     Abstract available
     
     
     
108. SHARMA RK, Lee J, Liou R, McManus C, et al
     Optimal surgeon-volume threshold for neck dissections in the setting of primary thyroid malignancies.
     Surgery. 2021 Jul 12. pii: S0039-6060(21)00541.
     PubMed     Abstract available
     
     
     
109. TAKAHASHI C, Shridhar R, Huston J, Blinn P, et al
     Comparative outcomes of transthoracic versus transhiatal esophagectomy.
     Surgery. 2021;170:263-270.
     PubMed     Abstract available
     
     
     June 2021
110. KARZAI S, Zhang Z, Sutton W, Prescott J, et al
     Ambient particulate matter air pollution is associated with increased risk of papillary thyroid cancer.
     Surgery. 2021 Jun 28. pii: S0039-6060(21)00415.
     PubMed     Abstract available
     
     
     
111. CREPEAU PK, Kulkarni K, Martucci J, Lai V, et al
     Comparing surgical thoroughness and recurrence in thyroid cancer patients across race/ethnicity.
     Surgery. 2021 Jun 11. pii: S0039-6060(21)00412.
     PubMed     Abstract available
     
     
     
112. LUI DTW, Fung MMH, Lee CH, Fong CHY, et al
     A territory-wide assessment of the incidence of persistent hypoparathyroidism after elective thyroid surgery and its impact on new fracture risk over time.
     Surgery. 2021 Jun 8. pii: S0039-6060(21)00423-2. doi: 10.1016/j.surg.2021.
     PubMed     Abstract available
     
     
     
113. YOU JY, Kim H, Park DW, Yang HW, et al
     Prevention of transoral thyroidectomy complications: An analysis of surgical outcomes in 423 consecutive series.
     Surgery. 2021 Jun 2. pii: S0039-6060(21)00422-0. doi: 10.1016/j.surg.2021.
     PubMed     Abstract available
     
     
     May 2021
114. LEE J, Ha EJ, Roh J, Kim HK, et al
     Presence of TERT +/- BRAF V600E mutation is not a risk factor for the clinical management of patients with papillary thyroid microcarcinoma.
     Surgery. 2021 May 2. pii: S0039-6060(21)00317-2. doi: 10.1016/j.surg.2021.
     PubMed     Abstract available
     
     
     
115. MORITANI S, Takenobu M, Yoshioka K, Kawamoto K, et al
     Novel surgical methods for reconstruction of the recurrent laryngeal nerve: Microscope-guided partial layer resection and intralaryngeal reconstruction of the recurrent laryngeal nerve.
     Surgery. 2021;169:1124-1130.
     PubMed     Abstract available
     
     
     April 2021
116. TANAKA K, Yamasaki M, Kobayashi T, Yamashita K, et al
     Postoperative pneumonia in the acute phase is an important prognostic factor in patients with esophageal cancer.
     Surgery. 2021 Apr 29. pii: S0039-6060(21)00312.
     PubMed     Abstract available
     
     
     
117. KRISHNA A, Mishra A, Mishra SK
     Comment on: Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer.
     Surgery. 2021 Apr 26. pii: S0039-6060(21)00236.
     PubMed    
     
     
     
118. OLIVER JR, Patel KN, Chang CM, Baldwin CK, et al
     Lymph node metastases in pediatric medullary thyroid carcinoma.
     Surgery. 2021 Apr 7. pii: S0039-6060(21)00193-8. doi: 10.1016/j.surg.2021.
     PubMed     Abstract available
     
     
     
119. ZAYDFUDIM VM
     Postoperative complications and long-term health-related quality of life (HRQOL) after esophagectomy.
     Surgery. 2021;169:988.
     PubMed    
     
     
     February 2021
120. CHOW KY, Kurumety S, Helenowski IB, Giri S, et al
     Association between quality of life and patient-reported complications from surgery and radioiodine in early-stage thyroid cancer survivors: A matched-pair analysis.
     Surgery. 2021 Feb 26. pii: S0039-6060(21)00060.
     PubMed     Abstract available
     
     
     
121. ZHANG X, Jiang L, Liu L, Liu B, et al
     Influence of body mass index at diagnosis on outcome of thyroid cancer in children and adolescents.
     Surgery. 2021 Feb 18. pii: S0039-6060(21)00029.
     PubMed     Abstract available
     
     
     January 2021
122. LANG BH, Fung MMH
     Intraoperative parathyroid hormone (IOPTH) assay might be better than the second-generation assay in parathyroidectomy for primary hyperparathyroidism.
     Surgery. 2021;169:109-113.
     PubMed     Abstract available
     
     
     November 2020
123. SHAHA AR, Tuttle RM
     Commentary: Re-recurrence after surgical management of recurrent thyroid cancer.
     Surgery. 2020 Nov 26. pii: S0039-6060(20)30743.
     PubMed    
     
     
     September 2020
124. SCHUMM MA, Ohev-Shalom R, Nguyen DT, Kim J, et al
     Measuring patient perceptions of surgeon communication performance in the treatment of thyroid nodules and thyroid cancer using the communication assessment tool.
     Surgery. 2020 Sep 24. pii: S0039-6060(20)30551.
     PubMed     Abstract available
     
     
     August 2020
125. WEBB C, Cronin P, Gupta N, Verhey J, et al
     Is thyroid cancer prognosis affected by solid organ transplantation?
     Surgery. 2020 Aug 16. pii: S0039-6060(20)30443.
     PubMed     Abstract available
     
     
     
126. HU X, Saunders N, Safley S, Smith MR, et al
     Environmental chemicals and metabolic disruption in primary and secondary human parathyroid tumors.
     Surgery. 2020 Aug 5. pii: S0039-6060(20)30370-6. doi: 10.1016/j.surg.2020.
     PubMed     Abstract available
     
     
     July 2020
127. SUBRAMANIAN C, Gorney R, Wang T, Ge D, et al
     A novel heat shock protein inhibitor KU757 with efficacy in lenvatinib-resistant follicular thyroid cancer cells overcomes up-regulated glycolysis in drug-resistant cells in vitro.
     Surgery. 2020 Jul 24. pii: S0039-6060(20)30369.
     PubMed     Abstract available
     
     
     
128. BORTZ MD, Kuchta K, Winchester DJ, Prinz RA, et al
     Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer.
     Surgery. 2020 Jul 15. pii: S0039-6060(20)30183.
     PubMed     Abstract available
     
     
     
129. DOUBLEDAY AR, Robbins SE, Macdonald CL, Elfenbein DM, et al
     What is the experience of our patients with transient hypoparathyroidism after total thyroidectomy?
     Surgery. 2020 Jul 9. pii: S0039-6060(20)30238-5. doi: 10.1016/j.surg.2020.
     PubMed     Abstract available
     
     
     May 2020
130. SUTTON W, Genberg B, Prescott JD, Segev DL, et al
     Understanding surgical decision-making in older adults with differentiated thyroid cancer: A discrete choice experiment.
     Surgery. 2020 May 28. pii: S0039-6060(20)30165.
     PubMed     Abstract available
     
     
     
131. CRAIG S, Khalil M, Eszlinger M, Itani D, et al
     Malignancy is in the eye of the beholder: Pathologic diagnosis of challenging follicular neoplasms in the era of noninvasive follicular thyroid neoplasms with papillary-like nuclear features and immunohistochemical and molecular adjuncts.
     Surgery. 2020 May 26. pii: S0039-6060(20)30184.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.